Heart Fatty Acid Binding Protein and cardiac troponin: Development of an optimal rule-out strategy for acute myocardial infarction

by Young, J.M, Pickering, J.W, George, P.M, Aldous, S.J, Wallace, J, Frampton, C.M, Troughton, R.W, Richards, M.A, Greenslade, J.H, Cullen, L, Than, M.P
Published 2020

Angiographic and platelet reactivity outcomes with prasugrel 60 mg pretreatment and clopidogrel 600 mg pretreatment in primary percutaneous coronary intervention

by Li, Y., Tai, B.-C., Sia, W., Phua, Q.-H., Richards, M.A., Low, A., Chan, K.-H., Teo, S.-G., Sim, T.-B., Lee, C.-H., Roe, M.T., Yeo, T.-C., Tan, H.-C., Chan, M.Y.
Published 2014

CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects

by Chan, M.Y., Tan, K., Tan, H.-C., Huan, P.-T., Li, B., Phua, Q.-H., Lee, H.-K., Lee, C.-H., Low, A., Becker, R.C., Ong, W.-C., Richards, M.A., Salim, A., Tai, E.-S., Koay, E.
Published 2014